Psoriatic arthritis: when the joints calm down and the pain doesn't.

Your rheumatologist says the inflammation is controlled. Your body says otherwise. There is a reason for that gap, and it can be worked on.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

What psoriatic arthritis is

Psoriatic arthritis, often shortened to PsA, is a form of joint inflammation that occurs in some people who have psoriasis, the skin condition that causes scaly, red patches. The immune system attacks the joints and the places where tendons attach to bone. The result is pain, swelling and stiffness that tend to flare and settle. Morning stiffness is common. Fingers or toes can swell up like sausages. The skin disease can be mild while the arthritis is not.

PsA is a structural, inflammatory disease. Left untreated it can damage joints, so diagnosis and treatment with a rheumatologist matter. Modern medicines, including biologics, are good at reducing inflammation for many people.

Here is the part that often gets missed. In a meaningful number of people, the blood tests improve, the swelling goes down, and the pain does not follow. That is where neuroplastic symptoms come in.

The neuroplastic contribution

Neuroplastic symptoms are real symptoms produced by learned pathways in the brain and nervous system, a sensitized alarm system, rather than by ongoing damage or disease in the tissue. They are not imaginary and not 'all in your head'. Because the brain can change, they are also reversible.

The ATNS Index of Neuroplastic Symptoms notes that psoriatic arthritis is not caused by neuroplastic symptoms. But it also states that in some patients a neuroplastic process contributes to what they feel, and that this is especially likely when the course of the condition over time, or the response to treatment, is not typical.

In practice, both things can be true at once:

• Your joints have genuine inflammation that medicine needs to control.
• Your nervous system, after months or years of pain, has learned to amplify signals and to sound the alarm even when inflammation is quiet.

Pain scientists call the second process central sensitization, or nociplastic pain. It is the same mechanism behind fibromyalgia, which overlaps heavily with PsA. You can read more about the three types of pain in our guide to nociceptive, neuropathic and nociplastic pain.

What the research shows

The evidence for a nervous-system contribution in PsA is growing, although most of it is cross-sectional, meaning it shows association rather than cause.

A cross-sectional study of 114 people with PsA found central sensitization, measured with a validated questionnaire, in about 43 percent of them, and neuropathic-type pain features in about a quarter. A separate study that deliberately excluded people with fibromyalgia still found central sensitization in a sizeable share of an unselected PsA clinic population, and those patients had more tender joints and were more likely to be classed as not responding to treatment. A review of fibromyalgia in PsA reports that between roughly 10 and 27 percent of people with PsA also meet fibromyalgia criteria, and discusses how joint inflammation may prime the spinal cord and brain to amplify pain.

Taken together, the research supports what the ATNS index describes: inflammation is the starting point, but in many people the nervous system becomes part of the problem, and that part does not respond to anti-inflammatory medicine alone.

Signs the brain may be part of the picture

• Your rheumatologist says disease activity is low or in remission, yet your pain is as bad as ever.
• Pain has spread beyond the joints that show swelling, into muscles, the back or 'everywhere'.
• You have tenderness to light pressure in many places, poor sleep, fatigue and brain fog, the pattern of fibromyalgia.
• Pain swings with stress, mood, sleep or worry more than with visible swelling.
• Several different biologics have not helped as much as expected.
• You find yourself scanning your body for the next flare and avoiding movement because you fear harm, the fear-avoidance cycle.

A solution that addresses it

If part of your pain is coming from a sensitized nervous system, that part can be retrained. Pain and symptom reprocessing is an approach built for exactly this. It includes education about neuroplastic symptoms, somatic tracking (observing sensations with curiosity instead of fear), reducing the sense of threat around pain, a graded return to activity, emotional awareness and expression, and acceptance and commitment skills. It is delivered by trained clinicians and, increasingly, through digital programs. It sits alongside your rheumatology care, not instead of it.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If your PsA pain has outrun your inflammation, you can join the waitlist.

What to do next

First, keep your rheumatology care on track. Do not stop or change any medication without talking to your doctor, and keep attending monitoring appointments. Report new swelling, hot joints, eye pain or redness, or any new skin changes promptly.

Second, ask your clinician a direct question: 'Does my pain match my inflammation?' If the answer is no, ask whether central sensitization or a fibromyalgia-type pattern could be contributing. Many rheumatologists now screen for this.

Third, if your symptoms fit the pattern above, start learning about neuroplastic pain and practising the skills that calm the alarm system. Our articles on fibromyalgia and ACT and on pacing are good places to begin.

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.